- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- 25 April
-
From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
- Home
- Cluster members
- Medica Group LLC
Medica Group LLC
Medica Group LLC is engaged in the localization of a joint Russian-Chinese project for the production of automatic microbiology analyzers on the territory of priority development in Novouralsk. The corresponding document was signed in the management company of the territory of advanced social and economic development (TASED) Atom- TOR. The project of localization of production in Russia was our response to the imposition of sanctions and threats of vital product lack. This project for the production of analyzers and culture vials gives us independence from foreign supplies.
Areas of company activities:
- Laboratory consumables;
- Modern solutions for microbiological laboratories;
- Medical equipment;
Clinical microbiology is an important link in the study of pathogenic features, pathogen diagnosis, rational use of antimicrobials and monitoring of nosocomial infection.
Sepsis is a fatal disease. About 30% of patients are misdiagnosed. This is due to the fact that current detection methods have low specificity and are slow. It takes days to get results, leading doctors to prescribe ineffective antibiotics, which in turn leads to the spread of antibiotic-resistant strains and increased deaths caused by blood infections. Every hour of delay in the use of effective antibiotics reduces survival by 7.6%. The introduction of innovative technologies in microbiological laboratories allows raising diagnostics to a new level, reducing the time for issuing results to 18-24 hours.
Automatic analyzers using advanced technology:
- YUNONA®LABSTAR model for testing the sterility of blood cultures and other biological fluids;
- Vials for blood cultures;
- YUNONA® HK model for identification of microorganisms and determination of sensitivity to antibiotics;
- Reagent kits for identification and sensitivity to antibiotics;
Automation of microbiological laboratories is an increase in the efficiency that directs the diagnosis, treatment and prevention of infectious diseases to obtain a quick and accurate diagnosis.
Medica Group of companies
Phone: +7 (343) 270-75-17
E-mail: medica.group@mail.ru
